Cementless Columbus Knee System Multiple components 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 B Braun Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2013-RN-00637-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2013-06-27
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    B. braun is withdrawing the cementless version of the columbus knee system from the australian register of therapeutic goods (artg) and is issuing a hazard alert to implanting surgeons. the decision to withdraw the cementless version of the columbus knee system was based on an analysis of data collected by the australian national joint replacement registry (njrr), which revealed that the cementless columbus knee system had a higher than acceptable revision rate.The cumulative revision rate (including all 33 revisions) for the cementless columbus knee system is 2.7% (95% ci: 1.6, 4.6) at one year from the time of implantation, 6.9% (95% ci: 4.8, 9.7) at three years, and 7.5% (95% ci: 5.3, 10.5) at five years, respectively, which is higher compared to all other total knee replacements with a cumulative revision rate of 1.0% (95% ci: 1.0, 1.0) at one year from the time of implantation, 2.7% (95% ci: 2.7, 2.8) at three years, and 3.6% (95% ci: 3.6, 3.7) at five years.
  • 조치
    Given the nature of the problem, orthopaedic surgeons are advised that there is no need to contact patients who have received an cementless Columbus Knee System additionally in addition to regular examinations; however, it is recommended that implanting surgeons conduct regular clinical and radiological examinations on those patients, in accordance with routine patient post-arthroplasty care, and advise them of this issue at that stage. For more details, please see http://www.tga.gov.au/safety/alerts-device-columbus-knee-system-130709.htm

Device

  • 모델명 / 제조번호(시리얼번호)
    Cementless Columbus Knee System Multiple componentsARTG Number: 96481
  • Manufacturer

Manufacturer